Clinical Trial Update: A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure [Phase 1]

View source ↗

Summary

Phase 1 trial comparing COREG CR with COREG CR fixed-dose combination in hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)
• COREG CR Fixed-dose Combination

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED